Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPS Therapeutique is a Canada-based private preclinical contract research organization focused on nonclinical drug development services for pharmaceutical and biotechnology clients. The company specializes in efficacy and safety assessment using validated disease models spanning cardiovascular, respiratory, coagulation, inflammatory, and metabolic disorders. Its service offering includes in vivo, ex vivo, and in vitro assays, including cardiovascular safety pharmacology, ion-channel and patch-clamp studies, isolated organ and tissue models, imaging, telemetry, flow cytometry, and metabolic and molecular profiling. IPS Therapeutique appears to operate as a service provider rather than a therapeutic product developer, supporting programs from discovery and lead optimization through IND-enabling work and regulatory support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPS Therapeutique.